DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
+10.81%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$2.53B
AUM Growth
+$2.53B
(+14%)
Cap. Flow
+$202M
Cap. Flow
% of AUM
7.99%
Top 10 Holdings %
Top 10 Hldgs %
33.99%
Holding
112
New
21
Increased
27
Reduced
21
Closed
14
Top Buys
| 1 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
$88.1M |
| 2 |
RVNC
Revance Therapeutics, Inc.
RVNC
|
$35.8M |
| 3 |
DBVT
DBV Technologies
DBVT
|
$35.7M |
| 4 |
DaVita
DVA
|
$30.7M |
| 5 |
LCI
Lannett Company, Inc.
LCI
|
$29.3M |
Top Sells
| 1 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$87.6M |
| 2 |
McKesson
MCK
|
$52.1M |
| 3 |
NXTM
NxStage Medical Inc.
NXTM
|
$43.6M |
| 4 |
Viatris
VTRS
|
$27.5M |
| 5 |
PDCO
Patterson Companies, Inc.
PDCO
|
$21.9M |
Sector Composition
| 1 | Healthcare | 78.98% |
| 2 | Financials | 0.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BPMC
26
DELISTED
Blueprint Medicines
BPMC
| $29.9M | 1.18% |
396,000
+193,000
| +95% | +$14.6M |
|
27
Elevance Health
ELV
$72.4B
| $29.3M | 1.15% |
+130,000
| New | +$29.3M |
|
|
AERI
28
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $28.9M | 1.14% |
484,055
-148,631
| -23% | -$8.88M |
|
29
Natera
NTRA
$23B
| $26.3M | 1.03% |
2,920,856
+739,314
| +34% | +$6.65M |
|
|
XLRN
30
DELISTED
Acceleron Pharma Inc.
XLRN
| $26.1M | 1.03% |
615,000
| – | – |
|
31
Acadia Healthcare
ACHC
$2.15B
| $24.2M | 0.95% |
+741,016
| New | +$24.2M |
|
|
EVHC
32
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $23.4M | 0.92% |
+676,000
| New | +$23.4M |
|
33
argenx
ARGX
$44.2B
| $23.1M | 0.91% |
365,961
-143,061
| -28% | -$9.03M |
|
|
IMMU
34
DELISTED
Immunomedics Inc
IMMU
| $21M | 0.83% |
1,300,448
+718,448
| +123% | +$11.6M |
|
|
OXFD
35
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $17.7M | 0.7% |
1,264,000
+318,290
| +34% | +$4.45M |
|
36
eHealth
EHTH
$126M
| $17.6M | 0.69% |
1,013,916
+340,922
| +51% | +$5.92M |
|
|
SCTL
37
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $17.6M | 0.69% |
1,901,685
| – | – |
|
38
Rhythm Pharmaceuticals
RYTM
$6.75B
| $16.9M | 0.67% |
+582,010
| New | +$16.9M |
|
|
AAC
39
DELISTED
AAC Holdings, Inc.
AAC
| $16.9M | 0.66% |
1,873,276
+140,000
| +8% | +$1.26M |
|
40
Ardelyx
ARDX
$1.57B
| $16.3M | 0.64% |
2,469,580
-276,900
| -10% | -$1.83M |
|
41
CytomX Therapeutics
CTMX
$350M
| $15.9M | 0.63% |
753,322
-3,500
| -0.5% | -$73.9K |
|
|
NVTA
42
DELISTED
Invitae Corporation
NVTA
| $15.6M | 0.62% |
1,723,000
+823,000
| +91% | +$7.47M |
|
43
Agios Pharmaceuticals
AGIO
$2.36B
| $15M | 0.59% |
262,984
+54,984
| +26% | +$3.14M |
|
44
Universal Health Services
UHS
$11.6B
| $15M | 0.59% |
+132,000
| New | +$15M |
|
|
PTLA
45
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $14.5M | 0.57% |
298,545
| – | – |
|
|
BLUE
46
DELISTED
bluebird bio
BLUE
| $14.2M | 0.56% |
+80,000
| New | +$14.2M |
|
|
LOXO
47
DELISTED
Loxo Oncology, Inc
LOXO
| $14.2M | 0.56% |
169,000
| – | – |
|
|
EPZM
48
DELISTED
Epizyme, Inc
EPZM
| $12.7M | 0.5% |
1,009,526
+309,000
| +44% | +$3.88M |
|
|
SYRS
49
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $12.3M | 0.49% |
1,268,945
| – | – |
|
50
Galapagos
GLPG
$2.06B
| $12.2M | 0.48% |
130,000
| – | – |
|